Another mechanism by which miR-29 exerts tumor suppressive effects in RMS is through targeting guanine nucleotide exchange factor T mRNA (ARHGEF25/GEFT), whose overexpression correlates with poorer outcomes (65). Here, ARHGEF25 is linked to neoplasm.